Andrzej Błauż

8PUBLICATIONS
16CO-AUTHORS
Characterisation of biological macromoleculesBiomolecular modelling and designBiologically active moleculesGlycoconjugatesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 21, 2026
N-Substituted colchicine analogues incorporating ferrocenyl and ruthenocenyl moieties: potent antiproliferative activity and substituent-dependent MDR profiles.

|Sep 18, 2024
Design and synthesis of ferrocenyl 1,4-dihydropyridines and their evaluation as kinesin-5 inhibitors.

Karolina Kowalczyk, Andrzej Błauż, Krzysztof Krawczyk

|Jul 19, 2023
Organometallic Ru, Os, Rh and Ir half-sandwich conjugates of ispinesib - impact of the organometallic group on the antimitotic activity.

Michał Łomzik, Andrzej Błauż, Marta Głodek

|Jun 18, 2023
Design, Synthesis, and Evaluation of Biological Activity of Ferrocene-Ispinesib Hybrids: Impact of a Ferrocenyl Group on the Antiproliferative and Kinesin Spindle Protein Inhibitory Activity.

Karolina Kowalczyk, Andrzej Błauż, Daniel Moscoh Ayine-Tora

|Nov 17, 2021
Impact of the ferrocenyl group on cytotoxicity and KSP inhibitory activity of ferrocenyl monastrol conjugates.

Anna Wieczorek-Błauż, Karolina Kowalczyk, Andrzej Błauż

|Jan 19, 2021
Synthesis and Biological Activity of Ferrocenyl and Ruthenocenyl Analogues of Etoposide: Discovery of a Novel Dual Inhibitor of Topoisomerase II Activity and Tubulin Polymerization.

Karolina Chrabąszcz, Andrzej Błauż, Martyna Gruchała

Pageof 2

Frequent Collaborators

8 joint publications

Damian Plażuk

8 joint publications

Błażej Rychlik

4 joint publications

Anna Wieczorek-Błauż

4 joint publications

Karolina Kowalczyk